AEON Biopharma Q2 2024 GAAP EPS $4.22 May Not Compare To $(0.19) Estimate
Portfolio Pulse from Benzinga Newsdesk
AEON Biopharma (AMEX:AEON) reported Q2 2024 GAAP EPS of $4.22, significantly surpassing the estimated $(0.19) by 2321.05%.
August 12, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AEON Biopharma reported Q2 2024 GAAP EPS of $4.22, significantly surpassing the estimated $(0.19) by 2321.05%.
AEON Biopharma's reported earnings per share (EPS) of $4.22 for Q2 2024 significantly exceeded the estimated $(0.19). This massive beat is likely to positively impact the stock price in the short term as it indicates strong financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100